EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Time-dependent recovery of renal impairment in patients with newly diagnosed multiple myeloma

Yoshikazu Utsu, Yuki Isono, Shin-Ichi Masuda, Hironori Arai, Sonoko Shimoji, Rena Matsumoto, Takafumi Tsushima, Kazusuke Tanaka, Kosuke Matsuo, Chiharu Kimeda, Shiho Konno, Yudai Yano und 2 weitere

Annals of Hematology · 2025

DOI: 10.1007/s00277-025-06201-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2025. Verfasst von Yoshikazu Utsu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Japan. yutsu@naritasekijyuji.jp. Hauptthemen laut MEDLINE: Multiple Myeloma, Renal Insufficiency, Recovery of Function. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal impairment is reported in 20%-50% of patients with newly diagnosed multiple myeloma and is known as a poor prognostic factor. Although several studies have demonstrated that treatment with novel antimyeloma agents improves renal impairment and myeloma itself, the time-dependent clinical course of recovery of renal function has not been extensively studied. We retrospectively collected the data of characteristics and outcomes in consecutive unselected patients diagnosed with and treated for symptomatic multiple myeloma between January 2015 and December 2022, and extracted and analyzed the cases with renal impairment. Among 234 patients with multiple myeloma, 67 (28.6%) had renal impairment (estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2) at the time of diagnosis. The median eGFR at diagnosis was 28 ml/min/1.73m2, and the eGFR significantly improved to 41.5 ml/min/1.73m2, which corresponds to a 42.9% increase, at 3 months after the initiation of treatment for myeloma (p < 0.0001). Further improvement in renal function was not observed at 6 months (eGFR 46 ml/min/1.73m2) and 1 year (eGFR 43.5 ml/min/1.73m2) after treatment initiation. The primary treatment was a bortezomib-containing regimen in approximately 90% of patients. A post hoc analysis revealed a positive correlation between the serum calcium concentration at diagnosis and improvement in renal function. In conclusion, renal function can partially recover through the treatment of multiple myeloma, and the treatment response during the first 3 months may predict the renal function prognosis. Further accumulation of cases is needed to identify the predictive factors for renal recovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaRenal InsufficiencyRecovery of FunctionHumansMaleFemaleAgedMiddle AgedRetrospective StudiesGlomerular Filtration RateBortezomibTime FactorsAged, 80 and overAdultAntineoplastic Combined Chemotherapy ProtocolsCalcium

Stichwörter der Autor:innen

Multiple myelomaMyeloma kidneyRenal functionRenal impairmenteGFR

Substanzen

BortezomibCalcium

Autor:innen und Institutionen

  • Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Japan. yutsu@naritasekijyuji.jp.
  • Department of Medical Oncology, Japanese Red Cross Narita Hospital, Narita, Japan. yutsu@naritasekijyuji.jp.
  • Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Japan.
  • Department of Medical Oncology, Japanese Red Cross Narita Hospital, Narita, Japan.
  • Department of Infectious Disease, Japanese Red Cross Narita Hospital, Narita, Japan.
  • Department of Nephrology, Japanese Red Cross Narita Hospital, Narita, Japan.

Zitieren

APA

Utsu, Y., Isono, Y., Masuda, S. I., Arai, H., Shimoji, S., Matsumoto, R., Tsushima, T., Tanaka, K., Matsuo, K., Kimeda, C., Konno, S., Yano, Y., Kuramoto, N., & Aotsuka, N. (2025). Time-dependent recovery of renal impairment in patients with newly diagnosed multiple myeloma. Annals of Hematology. https://doi.org/10.1007/s00277-025-06201-8

Vancouver

Utsu Y, Isono Y, Masuda SI, Arai H, Shimoji S, Matsumoto R, et al. Time-dependent recovery of renal impairment in patients with newly diagnosed multiple myeloma. Annals of Hematology. 2025. doi:10.1007/s00277-025-06201-8

BibTeX
@article{Utsu2025,
  author = {Utsu, Yoshikazu and Isono, Yuki and Masuda, Shin-Ichi and Arai, Hironori and Shimoji, Sonoko and Matsumoto, Rena and Tsushima, Takafumi and Tanaka, Kazusuke and Matsuo, Kosuke and Kimeda, Chiharu and Konno, Shiho and Yano, Yudai and Kuramoto, Nobuhiko and Aotsuka, Nobuyuki},
  title = {Time-dependent recovery of renal impairment in patients with newly diagnosed multiple myeloma},
  journal = {Annals of Hematology},
  year = {2025},
  doi = {10.1007/s00277-025-06201-8}
}
Kostenlos starten →